Successful Implantation and Live Birth Following Autologous Platelet-rich Plasma Treatment for a Patient with Recurrent Implantation Failure and Chronic Endometritis

In Vivo
Konstantinos SfakianoudisKonstantinos Pantos

Abstract

Patients diagnosed with chronic endometritis (CE) may fail to respond to standard antibiotic treatment. The driver behind the approach reported here was the imperative need for alternative therapeutic solutions. This case report presents a woman with CE and premature ovarian insufficiency having experienced repeated implantation failures following donated embryo transfers. The patient was diagnosed with CE through hysteroscopy, microbiological analysis and scanning electron microscopy. Following the suggested antibiotic treatment, she underwent a new embryo transfer, but with subsequent pregnancy loss. Following a second antibiotic scheme, all diagnostic procedures certified the persistence of CE. The patient underwent autologous, intrauterine platelet-rich plasma treatment and a subsequent embryo transfer. The diagnostic procedures indicated no signs of CE, while the embryo transfer resulted in a twin pregnancy and birth. Platelet-rich plasma may be employed as a first-line CE treatment, especially for patients who fail to respond to conventional antibiotic schemes.

Citations

Sep 10, 2020·Frontiers in Veterinary Science·Fausto CremonesiAnna Lange-Consiglio
May 5, 2020·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Marzieh ZamaniyanMohammad Hossein Mohammadi
Mar 17, 2021·Journal of Assisted Reproduction and Genetics·Fady I ShararaGaby N Moawad
Mar 20, 2021·Reproductive Biomedicine Online·Juan J EspinósUNKNOWN Spanish Infertility SWOT Group (SISG)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.